Overfeeding Polyunsaturated and Saturated Fat Causes Distinct Effects on Liver and Visceral Fat Accumulation in Humans
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Excess ectopic fat storage is linked to type 2 diabetes. The importance of dietary fat composition for ectopic fat storage in humans is unknown. We investigated liver fat accumulation and body composition during overfeeding saturated fatty acids (SFAs) or polyunsaturated fatty acids (PUFAs). LIPOGAIN was a double-blind, parallel-group, randomized trial. Thirty-nine young and normal-weight individuals were overfed muffins high in SFAs (palm oil) or n-6 PUFAs (sunflower oil) for 7 weeks. Liver fat, visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (SAT), total adipose tissue, pancreatic fat, and lean tissue were assessed by magnetic resonance imaging. Transcriptomics were performed in SAT. Both groups gained similar weight. SFAs, however, markedly increased liver fat compared with PUFAs and caused a twofold larger increase in VAT than PUFAs. Conversely, PUFAs caused a nearly threefold larger increase in lean tissue than SFAs. Increase in liver fat directly correlated with changes in plasma SFAs and inversely with PUFAs. Genes involved in regulating energy dissipation, insulin resistance, body composition, and fat-cell differentiation in SAT were differentially regulated between diets, and associated with increased PUFAs in SAT. In conclusion, overeating SFAs promotes hepatic and visceral fat storage, whereas excess energy from PUFAs may instead promote lean tissue in healthy humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to the current study, results from previous clinical trials showed lower liver fat concentrations in response to highunsaturated fatty acid than in response to high-SFA diets (10-12).”
In the citing paper
“The limited amount of evidence from human studies suggests that diets high in unsaturated fatty acids result in lower liver fat concentrations (10-12) as well as abdominal subcutaneous adipose tissue (aSCAT) (13) and VAT (12) than SFA-rich diets.”
In the citing paper
“The limited amount of evidence from human studies suggests that diets high in unsaturated fatty acids result in lower liver fat concentrations (10-12) as well as abdominal subcutaneous adipose tissue (aSCAT) (13) and VAT (12) than SFA-rich diets.”
In the citing paper
“This was particularly evident when the dietary fats were consumed in excess relative to daily energy requirements (11, 12) and/or when studies were performed in obese participants (10, 13).”
In the citing paper
“Previous findings were observed in the presence of hypercaloric diets and weight gain (11, 12) or were conducted in obese participants at greater risk of developing metabolic abnormalities (10, 11, 13).”
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“Biochemical Measures Fasting concentrations of plasma glucose and serum insulin were measured as previously described (22), and homeostasis model assessment of insulin resistance was calculated (24).”
MethodPioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327 · cited 1×
“Finally, it should be noted that sunflower oil contains more vitamin E than palm oil, and vitamin E supplementation has decreased steatosis (56).”
BackgroundEckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Miller, N. H., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437740.48606.d1 · Cited by 2,261
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907 · cited 1×
“Accumulation of liver fat, including non-alcoholic fatty liver disease (NAFLD), is present in ~25% of adults in Western countries and has been proposed as a causative factor in the development of cardiometabolic disorders and type 2 diabetes (4-8).”
BackgroundBody Fat Distribution and Risk of Cardiovascular Disease: An Update
Després, J.-P. (2012) · Circulation · doi:10.1161/circulationaha.111.067264 · Cited by 1,481
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265 · cited 1×
“In obesity, the prevalence of NAFLD is extremely high and may reach 75% (9).”
BackgroundIntrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972 · cited 1×
“Accumulation of liver fat, including non-alcoholic fatty liver disease (NAFLD), is present in ~25% of adults in Western countries and has been proposed as a causative factor in the development of cardiometabolic disorders and type 2 diabetes (4-8).”
BackgroundSarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937
Dietary fats and prevention of type 2 diabetes
Risérus, U., Willett, W. C., & Hu, F. B. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.10.002 · Cited by 753 · cited 1×
“Increased intake of these foods have in general been associated with cardiometabolic benefits including lowering blood lipids and reduced risk of CVD and type 2 diabetes (27-29).”
BackgroundSelf-citationLim, S., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Lim, J. Y., Park, K. S., & Jang, H. C. (2010) · Diabetes Care · doi:10.2337/dc10-0107 · Cited by 588 · cited 1×
“Although lean tissue was a secondary outcome, this finding is intriguing since obese persons with reduced lean tissue (sarcopenic obesity) are more insulin-resistant and at higher risk for physical disability (46,47).”
BackgroundComponents of a Cardioprotective Diet: New Insights
Mozaffarian, D., Appel, L. J., & Van Horn, L. (2011) · Circulation · doi:10.1161/circulationaha.110.968735 · Cited by 571 · cited 1×
“Increased intake of these foods have in general been associated with cardiometabolic benefits including lowering blood lipids and reduced risk of CVD and type 2 diabetes (27-29).”
BackgroundOmega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Parker, H. M., Johnson, N. A., Burdon, C. A., Cohn, J. S., O’Connor, H. T., & George, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.018 · Cited by 569 · cited 1×
“In the present study, n-6 PUFA was investigated, but it is possible that n-3 PUFA have similar effects on body fat accumulation (50-52).”
BackgroundDifferential oxidation of individual dietary fatty acids in humans
DeLany, J. P., Windhauser, M. M., Champagne, C. M., & Bray, G. A. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.4.905 · Cited by 560 · cited 1×
“PUFA is more readily oxidized than SFA (36-38), thereby potentially lowering hepatic exposure to non-esterified fatty acids, a major substrate in triglyceride synthesis.”
BackgroundBjermo, H., Iggman, D., Kullberg, J., Dahlman, I., Johansson, L., Persson, L., Berglund, J., Pulkki, K., Basu, S., Uusitupa, M., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.030114 · Cited by 490
Self-citationDiraison, F., Moulin, P., & Beylot, M. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70061-7 · Cited by 435 · cited 1×
“In NAFLD patients, increased de novo lipogenesis is a major contributor to liver fat accumulation and steatosis (31,32).”
Backgroundde Wit, N., Derrien, M., Bosch-Vermeulen, H., Oosterink, E., Keshtkar, S., Duval, C., de Vogel-van den Bosch, J., Kleerebezem, M., Müller, M., & van der Meer, R. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00488.2011 · Cited by 428
Central Obesity and Survival in Subjects With Coronary Artery Disease
Coutinho, T., Goel, K., Corrêa de Sá, D., Kragelund, C., Kanaya, A. M., Zeller, M., Park, J.-S., Kober, L., Torp-Pedersen, C., Cottin, Y., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.058 · Cited by 410 · cited 1×
“4 Fat accumulation in the liver, pancreas and abdomen may have long-term, adverse metabolic consequences (1-3).”
BackgroundPancreatic Fat Content and β-Cell Function in Men With and Without Type 2 Diabetes
Tushuizen, M. E., Bunck, M. C., Pouwels, P. J., Bontemps, S., van Waesberghe, J. H. T., Schindhelm, R. K., Mari, A., Heine, R. J., & Diamant, M. (2007) · Diabetes Care · doi:10.2337/dc07-0326 · Cited by 400
Retinaldehyde represses adipogenesis and diet-induced obesity
Ziouzenkova, O., Orasanu, G., Sharlach, M., Akiyama, T. E., Berger, J. P., Viereck, J., Hamilton, J. A., Tang, G., Dolnikowski, G. G., Vogel, S., et al. (2007) · Nature Medicine · doi:10.1038/nm1587 · Cited by 381 · cited 1×
“Interestingly, ALDH1A1-deficient mice are protected from diet-induced liver fat accumulation and insulin resistance (53).”
BackgroundDietary fat content modifies liver fat in overweight nondiabetic subjects
Westerbacka, J., Lammi, K., Häkkinen, A.-M., Rissanen, A., Salminen, I., Aro, A., & Yki-Järvinen, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1983 · Cited by 379 · cited 1×
“High-fat diets have been shown to increase liver fat in both humans and rodents when compared to low-fat diets (10-12).”
BackgroundSavard, C., Tartaglione, E. V., Kuver, R., Haigh, G. W., Farrell, G. C., Subramanian, S., Chait, A., Yeh, M. M., Quinn, L. S., & Ioannou, G. N. (2013) · Hepatology · doi:10.1002/hep.25789 · Cited by 295 · cited 1×
“Both groups in the current study consumed vegetable oils without any cholesterol, thus excluding any confounding effect of dietary cholesterol (55) that is abundant in SFAs from animal sources.”
BackgroundLess body fat accumulation in rats fed a safflower oil diet than in rats fed a beef tallow diet
Shimomura, Y., Tamura, T., & Suzuki, M. (1990) · The Journal of Nutrition · doi:10.1093/jn/120.11.1291 · Cited by 287 · cited 1×
“Animal studies have also indicated that SFA, compared with PUFA, lowers brown tissue adipose activity and thermogenesis (16-19, 39-45).”
BackgroundTiikkainen, M., Bergholm, R., Vehkavaara, S., Rissanen, A., Häkkinen, A.-M., Tamminen, M., Teramo, K., & Yki-Järvinen, H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.701 · Cited by 271 · cited 2×
“Cross-sectional studies have shown that patients with higher SFA and lower PUFA intake have increased liver fat content (13,15,25), which is also in accordance with lower PUFA levels in fatty livers (14,26).”
BackgroundAllard, J. P., Aghdassi, E., Mohammed, S., Raman, M., Avand, G., Arendt, B. M., Jalali, P., Kandasamy, T., Prayitno, N., Sherman, M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.09.009 · Cited by 247 · cited 2×
“Cross-sectional studies have shown that patients with higher SFA and lower PUFA intake have increased liver fat content (13,15,25), which is also in accordance with lower PUFA levels in fatty livers (14,26).”
BackgroundKotronen, A., Seppänen-Laakso, T., Westerbacka, J., Kiviluoto, T., Arola, J., Ruskeepää, A.-L., Orešič, M., & Yki-Järvinen, H. (2009) · Diabetes · doi:10.2337/db08-1074 · Cited by 245 · cited 2×
“Hepatic activity of the lipogenic enzyme SCD-1 may be elevated in steatosis (26).”
BackgroundResultFatty Acid–Regulated Transcription Factors in the Liver
Jump, D. B., Tripathy, S., & Depner, C. M. (2013) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161139 · Cited by 228
Sevastianova, K., Santos, A., Kotronen, A., Hakkarainen, A., Makkonen, J., Silander, K., Peltonen, M., Romeo, S., Lundbom, J., Lundbom, N., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.038695 · Cited by 211 · cited 1×
“In NAFLD patients, increased de novo lipogenesis is a major contributor to liver fat accumulation and steatosis (31,32).”
BackgroundLipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats.
Hill, J. O., Peters, J. C., Lin, D., Yakubu, F., Greene, H. L., & Swift, L. L. (1993) · PubMed · Cited by 196
Kotronen, A., Juurinen, L., Hakkarainen, A., Westerbacka, J., Cornér, A., Bergholm, R., & Yki-Järvinen, H. (2008) · Diabetes Care · doi:10.2337/dc07-1463 · Cited by 196 · cited 1×
“Accumulation of liver fat, including non-alcoholic fatty liver disease (NAFLD), is present in ~25% of adults in Western countries and has been proposed as a causative factor in the development of cardiometabolic disorders and type 2 diabetes (4-8).”
BackgroundPiers, L., Walker, K., Stoney, R., Soares, M., & O'Dea, K. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801993 · Cited by 187 · cited 1×
“PUFA is more readily oxidized than SFA (36-38), thereby potentially lowering hepatic exposure to non-esterified fatty acids, a major substrate in triglyceride synthesis.”
BackgroundFatty acid synthesis during early linoleic acid deficiency in the mouse
Allmann, D. W., & Gibson, D. M. (1965) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39639-5 · Cited by 184
Boberg, M., Croon, L. B., Gustafsson, I.-B., & Vessby, B. (1985) · Clinical Science · doi:10.1042/cs0680581 · Cited by 178 · cited 1×
“Fatty acid composition was measured in the intervention oils as well as in plasma cholesterol esters and adipose tissue triglycerides by gas chromatography as previously described (22,23).”
MethodNorris, L. E., Collene, A. L., Asp, M. L., Hsu, J. C., Liu, L.-F., Richardson, J. R., Li, D., Bell, D., Osei, K., Jackson, R. D., et al. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27371 · Cited by 171 · cited 1×
“A previous supplementation trial in postmenopausal women reported that a daily dose of 8 g PUFA (safflower oil) increased lean tissue and reduced trunk fat (48).”
MethodTakeuchi, H., Matsuo, T., Tokuyama, K., Shimomura, Y., & Suzuki, M. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.4.920 · Cited by 162 · cited 1×
“Animal studies have also indicated that SFA, compared with PUFA, lowers brown tissue adipose activity and thermogenesis (16-19, 39-45).”
BackgroundSobrecases, H., Lê, K.-A., Bortolotti, M., Schneiter, P., Ith, M., Kreis, R., Boesch, C., & Tappy, L. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.03.003 · Cited by 161 · cited 1×
“14 fat is possible since the muffins contained significant amounts of fructose (33).”
BackgroundMercer, S. W., & Trayhurn, P. (1987) · The Journal of Nutrition · doi:10.1093/jn/117.12.2147 · Cited by 146 · cited 2×
“In addition, animals fed high-fat diets with PUFA reduced body and liver fat accumulation compared to SFA diets (16-21).”
Backgroundvan Herpen, N. A., Schrauwen-Hinderling, V. B., Schaart, G., Mensink, R. P., & Schrauwen, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2243 · Cited by 124
de Meijer, V. E., Le, H. D., Meisel, J. A., Sharif, M. R. A., Pan, A., Nosé, V., & Puder, M. (2010) · Metabolism · doi:10.1016/j.metabol.2009.11.006 · Cited by 121
Dietary Fatty Acid Composition Influences Energy Accretion in Rats
Su, W., & Jones, P. J. H. (1993) · Journal of Nutrition · doi:10.1093/jn/123.12.2109 · Cited by 104 · cited 1×
“In accordance, rats isocalorically fed with PUFAs (high in linoleic acid) gained more lean tissue and less fat compared with an SFA-rich diet, in line with similar studies (16,17,49,50).”
ResultPolyunsaturated fatty acids recruit brown adipose tissue: increased UCP content and NST capacity
Sadurskis, A., Dicker, A., Cannon, B., & Nedergaard, J. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.2.e351 · Cited by 90 · cited 1×
“Animal studies have also indicated that SFA, compared with PUFA, lowers brown tissue adipose activity and thermogenesis (16-19, 39-45).”
BackgroundDulloo, A. G., Mensi, N., Seydoux, J., & Girardier, L. (1995) · Metabolism · doi:10.1016/0026-0495(95)90277-5 · Cited by 79 · cited 3×
“In addition, animals fed high-fat diets with PUFA reduced body and liver fat accumulation compared to SFA diets (16-21).”
BackgroundResultKotronen, A., Yki‐Järvinen, H., Sevastianova, K., Bergholm, R., Hakkarainen, A., Pietiläinen, K. H., Juurinen, L., Lundbom, N. M. I., & Sørensen, T. I. A. (2010) · Obesity · doi:10.1038/oby.2010.137 · Cited by 77 · cited 1×
“Accumulation of liver fat, including non-alcoholic fatty liver disease (NAFLD), is present in ~25% of adults in Western countries and has been proposed as a causative factor in the development of cardiometabolic disorders and type 2 diabetes (4-8).”
BackgroundKim, L. J., Nalls, M. A., Eiríksdóttir, G., Sigurdsson, S. O., Launer, L. J., Koster, A., Chaves, P. H. M., Jónsdóttir, B., García, M., Gudnason, V. G., et al. (2010) · Obesity · doi:10.1038/oby.2010.291 · Cited by 71 · cited 1×
“Accumulation of liver fat, including non-alcoholic fatty liver disease (NAFLD), is present in ~25% of adults in Western countries and has been proposed as a causative factor in the development of cardiometabolic disorders and type 2 diabetes (4-8).”
BackgroundHepatic and adipose tissue lipogenic enzyme mRNA levels are suppressed by high fat diets in the rat.
Shillabeer, G., Hornford, J., Forden, J., Wong, N., & Lau, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42830-5 · Cited by 69
Jans, A., Konings, E., Goossens, G. H., Bouwman, F. G., Moors, C. C. M., Boekschoten, M. V., Afman, L. A., Müller, M. M., Mariman, E. C. M., & Blaak, E. E. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.028787 · Cited by 63
Takeuchi, H., Matsuo, T., Tokuyama, K., & Suzuki, M. (1995) · Journal of Nutrition · doi:10.1093/jn/125.9.2364 · Cited by 61 · cited 1×
“Animal studies have also indicated that SFA, compared with PUFA, lowers brown tissue adipose activity and thermogenesis (16-19, 39-45).”
BackgroundMatsuo, T., Takeuchi, H., Suzuki, H., & Suzuki, M. (2002) · Asia Pacific Journal of Clinical Nutrition · doi:10.1046/j.1440-6047.2002.00299.x · Cited by 52 · cited 2×
“In addition, animals fed high-fat diets with PUFA reduced body and liver fat accumulation compared to SFA diets (16-21).”
BackgroundEffects of Dietary Essential Fatty Acids on Active Thermogenin Content in Rat Brown Adipose Tissue
Nedergaard, J., Becker, W., & Cannon, B. (1983) · Journal of Nutrition · doi:10.1093/jn/113.9.1717 · Cited by 47 · cited 1×
“Animal studies have also indicated that SFA, compared with PUFA, lowers brown tissue adipose activity and thermogenesis (16-19, 39-45).”
BackgroundPetit, J. M., Guiu, B., Duvillard, L., Jooste, V., Brindisi, M., Athias, A., Bouillet, B., Habchi, M., Cottet, V., Gambert, P., et al. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.12.007 · Cited by 47
Kurikawa, N., Takagi, T., Wakimoto, S., Uto, Y., Terashima, H., Kono, K., Ogata, T., & Ohsumi, J. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00702 · Cited by 42
Petersson, H., Ärnlöv, J., Zethelius, B., & Risérus, U. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.11.019 · Cited by 37 · cited 2×
“Cross-sectional studies have shown that patients with higher SFA and lower PUFA intake have increased liver fat content (13,15,25), which is also in accordance with lower PUFA levels in fatty livers (14,26).”
BackgroundSelf-citationRonis, M. J. J., Baumgardner, J. N., Marecki, J. C., Hennings, L. J., Wu, X., Shankar, K., Cleves, M. A., Gómez-Acevedo, H., & Badger, T. M. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00069.2012 · Cited by 30 · cited 1×
“However, a recent animal study (54) investigated the Figure 3—Correlations between changes in outcome measures and changes in plasma cholesterol esters.”
BackgroundYepuri, G., Marcelino, H., Shahkhalili, Y., Aprikian, O., Macé, K., Seydoux, J., Miles-Chan, J. L., Montani, J., & Dulloo, A. G. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114510005659 · Cited by 22
Crescenzo, R., Bianco, F., Falcone, I., Tsalouhidou, S., Yepuri, G., Mougios, V., Dulloo, A. G., Liverini, G., & Iossa, S. (2011) · Obesity · doi:10.1038/oby.2011.167 · Cited by 20 · cited 3×
“In addition, animals fed high-fat diets with PUFA reduced body and liver fat accumulation compared to SFA diets (16-21).”
BackgroundResultBecker, W. (1984) · Journal of Nutrition · doi:10.1093/jn/114.9.1690 · Cited by 19 · cited 1×
“Animal studies have also indicated that SFA, compared with PUFA, lowers brown tissue adipose activity and thermogenesis (16-19, 39-45).”
BackgroundBeef Tallow Diet Decreases Uncoupling Protein Content in the Brown Adipose Tissue of Rats.
Matsuo, T., Komuro, M., & Suzuki, M. (1996) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.42.595 · Cited by 13 · cited 1×
“Animal studies have also indicated that SFA, compared with PUFA, lowers brown tissue adipose activity and thermogenesis (16-19, 39-45).”
Background
Cited by
Mozaffarian, D. (2016) · Circulation · doi:10.1161/circulationaha.115.018585 · Cited by 2,216
“In controlled trials, in comparison with saturated fat, LA reduces hepatic steatosis and systemic inflammation and increases lean muscle mass.(366,367) Arachidonic acid, the prototypical metabolite of LA, is also commonly considered proinflammatory, but is also the natural precursor to specialized proresolving mediato…”
Treatment of NAFLD with diet, physical activity and exercise
Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.016 · Cited by 1,347
“In a 7-week RCT overeating SFAs or omega 6-PUFAs led to a similar weight gain, but the SFAs markedly increased liver fat compared with PUFAs and caused a twofold increase in visceral fat compared to PUFAs.20 Similarly, a 10-week RCT of isocaloric diets demonstrated that intake of omega 6-PUFAs reduced liver fat compar…”
BackgroundEpigenetics in Human Obesity and Type 2 Diabetes
Ling, C., & Rönn, T. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.009 · Cited by 941
Biological and Nutritional Properties of Palm Oil and Palmitic Acid: Effects on Health
Mancini, A., Imperlini, E., Nigro, E., Montagnese, C., Daniele, A., Orrù, S., & Buono, P. (2015) · Molecules · doi:10.3390/molecules200917339 · Cited by 557
Imamura, F., Micha, R., Wu, J. H. Y., de Oliveira Otto, M. C., Otite, F. O., Abioye, A. I., & Mozaffarian, D. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002087 · Cited by 479
Metadata
- Authors
- Rosqvist, F., Iggman, D., Kullberg, J., Cedernaes, J., Johansson, H.-E., Larsson, A., Johansson, L., Ahlström, H., Arner, P., Dahlman, I., & Risérus, U.
- Affiliations
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Corresponding author
- Risérus, Ulf
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-06-14
- Volume
- 63
- Issue
- 7
- Pages
- 2356-2368
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2171699937
- Semantic Scholar
- 192527fa7ae74fb3db2ee7f00e76335166d7e4aa
- Cited by
- 429
- References
- 56
- Citations by year
- 2026: 26 · 2025: 30 · 2024: 48 · 2023: 39 · 2022: 50 · 2021: 40 · 2020: 44 · 2019: 36 · 2018: 29 · 2017: 27 · 2016: 28 · 2015: 23 · 2014: 9
- FWCI
- 23.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Novo Nordisk Fonden (NNF12OC1016371)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- saturated fatty acids, polyunsaturated fatty acids, dietary fat composition, overfeeding, hepatic lipid accumulation, visceral adipose tissue, subcutaneous adipose tissue, type 2 diabetes, lean tissue, adipose tissue gene expression, insulin resistance, energy dissipation, palm oil, sunflower oil, body composition
- MeSH terms
- Adult, Body Composition, Fatty Acids, Fatty Acids, Unsaturated, Female, Humans, Liver, Male, Viscera, Overnutrition, Intra-Abdominal Fat, Lipid Metabolism, Young Adult, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.